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Genome-Wide Expression Analysis of Human In Vivo
Irritated Epidermis: Differential Profiles Induced
by Sodium Lauryl Sulfate and Nonanoic Acid
Anders Clemmensen1, Klaus E. Andersen1, Ole Clemmensen2, Qihua Tan3, Thomas K. Petersen4,
Torben A. Kruse3 and Mads Thomassen3
The pathogenesis of irritant contact dermatitis (ICD) is poorly understood, and genes participating in the
epidermal response to chemical irritants are only partly known. It is commonly accepted that different irritants
have different mechanisms of action in the development of ICD. To define the differential molecular events
induced in the epidermis by different irritants, we collected sequential biopsies (12, 4, and 24 hours after a single
exposure and at day 11 after repeated exposure) from human volunteers exposed to either sodium lauryl sulfate
(SLS) or nonanoic acid (NON). Gene expression analysis using high-density oligonucleotide microarrays
(representing 47,000 transcripts) revealed essentially different pathway responses 12hours after exposure: NON
transiently induced the IL-6 pathway as well as a number of mitogen-activated signaling cascades including
extracellular signal-regulated kinase and growth factor receptor signaling, whereas SLS transiently down-
regulated cellular energy metabolism pathways. Differential expression of the cyclooxygenase-2 and matrix
metalloproteinase 3 transcripts was confirmed immunohistochemically. After cumulative exposure, 883 genes
were differentially expressed, whereas we identified 23 suggested common biomarkers for ICD. In conclusion,
we bring new insights into two hitherto less well-elucidated phases of skin irritancy: the very initial as well as
the late phase after single and cumulative mild exposures, respectively.
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INTRODUCTION
Irritant contact dermatitis (ICD) in its most frequent form—
i.e., chronic ICD—most commonly results from repeated
exposures to weak irritants. Chronic ICD is a common
problem in occupational dermatology, and its pathogenesis
remains largely unknown. The clinical expression and course
depends on the irritant and mode of exposure: The picture of
acutely irritated skin is divergent from that seen in cumulative
skin irritation (Malten, 1981). Investigators have induced ICD
experimentally in various ways to examine the natural history
of the disease, and while most data on the pathogenesis of
ICD derive from acute irritation studies (most frequently a
patch test), knowledge of mechanisms of action in cumula-
tive skin irritation is sparse (De Jongh et al., 2006). However,
cumulative skin irritation models are judged to mimic
everyday exposure for patients more closely than a patch test.
It has been established that different chemicals have
diverse actions on the skin (Willis et al., 1989; Wilmer et al.,
1994; Holliday et al., 1997). Sodium lauryl sulfate (SLS) is an
irritant of the corrosive type and may—even in subclinical
reactions—result in impairment of the water barrier function
of the skin (Tupker et al., 1997), whereas nonanoic acid
(NON) induces irritancy of the noncorrosive type—i.e., the
water barrier is not always affected (Fullerton et al., 2002;
Wahlberg and Lindberg, 2003). The diversity of skin reactions
caused by SLS and NON is recognized clinically (Reiche
et al., 1998), instrumentally (Agner and Serup, 1989), histo-
pathologically and ultrastructurally (Willis et al., 1989; Forsey
et al., 1998), immunohistochemically (Lindberg et al., 1991),
and transcriptionally (Grangsjo et al., 1996). Moreover,
treatment responses may be different for cumulative skin
exposure to SLS compared with NON (Andersen et al., 2007).
Gene expression studies in ICD have focused on pro-
inflammatory cytokines responsible for initiation of the
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inflammation cascade (Corsini and Galli, 2000; Lisby and
Baadsgaard, 2006). However, given the complex cellular
response mechanisms and multiple interactions of resident
skin cells, genes involved specifically in ICD are supposedly
only partly known. The technique of microarray gene chips
offers expression analysis of a large number of genes
simultaneously. Until now, studies using this technique have
shed new light on skin irritation in humans (Marionnet et al.,
2003; Wong et al., 2004), rats (Rogers et al., 2003; McDougal
et al., 2007), and in vitro skin cultures (Fletcher et al., 2001;
Borlon et al., 2007).
The purpose of this study was to use microarrays represent-
ing 47,000 transcripts to analyze the epidermal transcriptional
changes on irritation as it may occur in real life with the main
focus on differences between SLS and NON. By collecting skin
biopsies from three early and one late time point, transcrip-
tional profiles of cumulative skin irritancy over time were
investigated. In this study, we show different gene expression
profiles between SLS- and NON-irritated epidermis as well as
highly changed transcripts equivalently regulated by the two
irritants after cumulative exposure.
RESULTS
Skin irritation obtained by SLS and NON
The cumulative course of irritation is shown in Supplementary
Figure S1 online showing a comparable level of clinical
irritation for the two irritants. The mean clinical score at day 11
was within the target level of irritation (score of at least 2, but
not higher than 4 corresponding to a moderate reaction).
Biometric measurements are summarized as changes at day 11
compared with baseline values in Supplementary Table S1
online. Although D clinical score and D TEWL (transepidermal
water loss) was comparable for the two irritants, NON had a
more drying effect than SLS as shown by the larger decrease in
stratum corneum hydration. Erythema as determined by
colorimetry was increased by SLS but hardly affected at all
by NON. After the single exposure (i.e., at time points 12, 4, and
24hours), skin hydration was the only affected parameter for
both irritants, as it was substantially decreased after 12 hour,
remained low at 4hours, and then nearly restored at 24hours.
SLS and NON induce asymmetrical overall expression profiles
Sequentially obtained RNA was hybridized to Affymetrix
(Santa Clara, CA) GeneChips to characterize mechanisms
induced by NON and SLS over time. Significantly changed
transcripts at different time points were identified for both
irritants separately using a linear mixed effect (LME) model
approach with a false discovery rate (FDR) correction. The
overall expression is summarized in Supplementary Figure S2
online showing different patterns by the two irritants. Fold
changes and q-values for top 50 uppermost changed (both
up- and downregulated) transcripts are shown for both
irritants at all time points in Supplementary Table S2 online.
Significant irritant-discriminative genes are predominantly
found at day 11
Identification of genes that were regulated differently by
exposure to the two irritants was one of the main aims of the
experiment. A t-test comparison between irritants both
separately for each time point and combined for time points
1
2, 4, and 24 hours disclosed no discriminative genes when
FDR correction was applied. The top-differentially regulated
genes for combined early time points are shown in a heat
map in Supplementary Figure S3 online. The most differen-
tially expressed early gene was matrix metalloproteinase 3,
MMP3 (uncorrected P-value¼ 0.000096) that was more
highly expressed in response to SLS. Among the 10 upper-
most early differentially expressed genes, two attracted
special interest because they were each represented with
two different probe sets: the insulin-like growth factor (IGF)
binding protein IGFBP3 (P¼0.0003 and 0.0005) and the
noncoding maternally imprinted gene H19 (P¼0.0002 and
0.0006) that were both less expressed in response to SLS.
An LME analysis including all chips in the experiment
identified 883 irritant-discriminative transcripts (FDRo0.05),
and visualization of these 883 genes in a heat map showed
that the day 11 response was by far the most powerful
compared with the early time points (Figure 1a). In summary,
looking at the overall expression pattern in the whole data
set, day 11 was identified as the main contributor not only of
significantly changed genes but also of genes that would
pinpoint differences between the two irritants.
Most upregulated early response genes at 12 hour are quickly
turned off
The top 15 significantly upregulated genes (as identified by
LME with FDR) for both irritants at 12 hour are shown in
Figure 2 allowing the reader to follow their expression over
time. Many genes are upregulated in parallel for both
irritants; the majority are rapidly upregulated and then
quickly switched off from 4hours and onward. The transcripts
FOS, DUSP1 (dual-specific phosphatase 1), and the Affyme-
trix probe set 240053_x_at were actually among the top 10
upregulated transcripts for both irritants at 12 hour and may
thus be upregulated in skin irritation irrespective of the irritant
applied. Conversely, transcripts such as AMBRA1 and XIRP2
(upregulated by NON and SLS, respectively) were dissim-
ilarly regulated at 12 hour, and for the transcript 207737_at a
divergent pattern was sustained over time.
Gene expression at the end of cumulative irritation (day 11)
Table 1 show 26 transcripts that were among the top 50
regulated (up or down) transcripts for both SLS and NON at
day 11. Thus, these transcripts (representing 23 genes) may
represent common biomarkers for cumulative irritant derma-
titis irrespective of the chemical nature of the irritant. The
occurrence of several probe sets per gene and overlapping
genes between irritants serves as an internal validation of
the study.
To characterize differences between irritant responses
further, we subjected the 883 irritant-discriminative genes
identified by LME (Figure 1a) to a cluster analysis (Figure 1b).
Three clusters were formed: cluster A identified genes
upregulated by NON and downregulated by SLS. The same
was the case for cluster B but only one NON-treated subject
seemed to contribute substantially to this pattern. The last
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Figure 1. Differential gene expression induced by nonanoic acid (NON) and sodium lauryl sulfate (SLS). (a) Cluster of 883 significant irritant-discriminative
transcripts identified by linear mixed effect (LME) (false discovery rate (FDR) o 0.05). The differences are predominantly found at day 11 (d11; purple color).
Dark and light color tones within each time point indicate NON and SLS exposure, respectively. (b) Clustering of the same 883 transcripts as in a using d11 chips
only. Clusters A (containing 290 transcripts) and C (containing 352 transcripts) are summarized by subsequent pathway overrepresentation analysis (MSigDB,
canonical pathways; Po0.05).
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Figure 2. Significantly upregulated genes after 12 hour compared for sodium lauryl sulfate (SLS) and nonanoic acid (NON) over time. Top 15 significantly
changed genes for NON (upper part) and SLS (lower part) as determined by linear mixed effect (LME) with false discovery rate (FDR) correction. The expression is
shown for all chips in the experiment. Up- and downregulation is depicted in red and green, respectively. Transcripts marked with *were also significantly
upregulated (FDRo0.05) by the other irritant.
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Table 1. Gene transcripts regulated in parallel by SLS and NON at day 11
Affymetrix ID Gene symbol Gene title Synonym q-value Fold change
NON SLS NON SLS
Upregulated
Epidermal differentiation
211906_s_at SERPINB4 Serpin peptidase inhibitor,
clade B (ovalbumin), member 4
Squamous cell carcinoma
antigen 2
0.01415 0.00065 7.38 20.76
203535_at S100A9 S100 calcium-binding protein A9 Calgranulin B 0.00359 1.16E05 3.69 13.95
224328_s_at LCE3D Late cornified envelope 3D Small proline rich-like 6A 0.00203 3.20E05 3.00 4.05
202917_s_at S100A8 S100 calcium-binding protein A8 Calgranulin A 0.02806 8.68E06 2.88 7.58
210413_x_at SERPINB4 Serpin peptidase inhibitor, clade B
(ovalbumin), member 4
Squamous cell carcinoma
antigen 2
7.66E06 8.75E05 2.81 4.11
209720_s_at SERPINB3 Serpin peptidase inhibitor, clade B
(ovalbumin), member 3
Squamous cell carcinoma
antigen 1
0.00092 0.00022 2.76 5.05
209719_x_at SERPINB3 Serpin peptidase inhibitor, clade B
(ovalbumin), member 3
Squamous cell carcinoma
antigen 1
3.36E06 3.08E05 2.74 3.75
213796_at SPRR1A Small proline-rich protein 1A Cornifin A 0.00050 0.00016 2.52 5.17
Cell cycle
209891_at SPC25 SPC25, NDC80 kinetochore complex
component, homolog (S. cerevisiae)
— 0 0 2.29 3.6
201291_s_at TOP2A Topoisomerase (DNA) II alpha 170 kDa — 3.37E13 0.00089 2.27 3.58
202095_s_at BIRC5 Baculoviral IAP repeat-containing 5 Survivin 0 9.17E15 2.23 3.16
Miscellaneous
212531_at LCN2 Lipocalin 2 Neutrophil gelatinase-
associated lipocalin
0.00924 0.0021 3.41 5.28
1569428_at WIBG Within bgcn homolog (Drosophila) — 0.00683 0.0003 2.29 2.83
1553396_a_at CCDC13 Coiled-coil domain containing 13 — 0.00574 0.00186 2.31 2.99
Downregulated
Cell adhesion
228706_s_at CLDN23 Claudin 23 — 0.00300 0.00190 2.89 10.24
228707_at CLDN23 Claudin 23 — 0.02558 0.00016 2.41 10.16
Cell growth
231148_at IGFL2 IGF-like family member 2 — 0.01306 0.00054 2.32 4.14
Enzymatic activity
215554_at GPLD1 Glycosylphosphatidylinositol-specific
phospholipase D1
Glycoprotein
phospholipase D
0.00017 3.87E12 2.39 6.05
209460_at ABAT 4-Aminobutyrate aminotransferase GABA transferase 0.0085 8.66E13 2.51 4.77
1553734_at AK7 Adenylate kinase 7 — 0.01259 1.65E05 2.36 4.96
Epidermal differentiation
1554921_a_at SCEL Sciellin — 0.04683 0.00081 2.5 11.45
Sterol biosynthesis
213562_s_at SQLE Squalene epoxidase Squalene monoxidase 1.69E05 0.000144 2.17 4.24
Table 1 continued on the following page
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pattern represented by cluster C showed a general picture of
upregulated transcripts in response to both irritants; however,
the upregulation was much more prominent in response to SLS.
We analyzed cluster A versus C to functionally summarize
the transcripts and to enable biological interpretation of the
changed transcripts. A hypergeometric overrepresentation
analysis using the MSigDB database overlap calculation for
canonical pathways showed both overlapping and distinct
pathways for the two irritants (Figure 1b).
Pathway analysis (Gene Set Enrichment Analysis)
Pathway analysis in large-scale gene expression experiments
is based on small but consistent changes in expression of a
group of genes with related function (Curtis et al., 2005). We
identified significantly regulated pathways associated with
skin irritation using paired Gene Set Enrichment Analysis.
Twenty pathways were found after 12 hour (Supplementary
Table S3 online). All were upregulated in response to NON,
and these mainly inflammatory (e.g., IL-6 and T-cell
receptor), mitogenic (e.g., IGF1 and platelet-derived growth
factor), and even cancer-related pathways share many
upregulated genes (Supplementary Figure S4 online). These
genes are primarily associated with intracellular signaling,
such as the mitogen-activated protein kinase (MAPK)
pathways (RAF1, MAP2K1þ 2, MAPK1, MAPK8), signaling
molecules downstream to membrane-bound growth factor/
cytokine receptor activation (GRB2, SOS, PIK3R1, PRKCB1,
RAC1), intracellular calcium signaling (CALM1þ2,
PPP3CC), and MAPK-activated transcription factors (Elk-1,
and the activator protein 1 (AP-1) subunits FOS and JUN). In
contrast, SLS did not induce the significant regulation of any
pathways by paired analysis after 12 hour despite the over-
weight in significantly changed transcripts identified by LME
(Supplementary Figure S2 online). At time points 4 hours,
24 hours, and day 11, paired analysis did not result in any
significantly regulated pathways for any of the irritants, which
we ascribe the small number of chips (3 vs. 3). However,
an unpaired analysis with the inclusion of more chips
(Supplementary Table S4 online) indicated that the 12 hour
response to SLS is associated with downregulation of cell
energy metabolism (such as tricarboxylic acid cycle, fatty
acid b-oxidation and protein metabolism) as well as
cholesterol biosynthesis. Significantly regulated pathways at
time point 4 and 24 hours were very sparse with focal
adhesion/extracellular matrix receptor interaction being
upregulated by NON at both 4 and 24 hours possibly
indicating keratinocyte dyscohesion.
The differential early response between the irritants was
confirmed by a 6 vs. 6 chips comparison using all 12 hour
chips in the experiment (Supplementary Table S5 online). The
core message being that central cell energy metabolism
pathways and steroid/cholesterol biosynthesis are differen-
tially regulated in response to the two irritants.
Taken together, the above analyses indicate that growth,
pro-survival, and inflammation-related pathways are signifi-
cantly upregulated in the very early epidermal response to
NON, whereas in SLS irritation a downregulation in cellular
catabolic as well as anabolic pathways could be shown.
Histopathological changes are absent at early time points and
sparse at day 11
There were hardly any histopathological changes from
baseline through the time points 12, 4, and 24 hours. At day
11, both irritants induced slight acanthosis, hyperkeratosis
(Figure 3a-c), and perivascular lymphocytic infiltration
(Figure 3d-f), and the increase in all three parameters was
more pronounced in response to SLS than NON. Occasional
sparse parakeratosis was seen (n¼ 4) and was not restricted to
any irritant. The increased transcription of cell-cycle genes at
day 11 was supported indirectly by an increased immunos-
taining with the mitosis-specific antibody MIB-1. However,
the anticipated difference between irritants as determined by
canonical pathways (Figure 1b) could not be confirmed
(Figure 3g-i).
Altogether, the histopathological changes at day 11 were
smaller than might have been expected from clinical
appearances.
Immunohistochemical analysis confirmed dissimilar expression
of MMP3 and COX-2
From transcriptional results one might hypothesize that
S100A7 were induced by SLS (FDR¼ 0.021, Supplementary
Table S2 online) and not by NON (FDR¼0.145) after
cumulative exposure. However, both irritants induced an
Table 1. Continued
Affymetrix ID Gene symbol Gene title Synonym q-value Fold change
NON SLS NON SLS
Unknown
233045_at LOC286126 Hypothetical protein LOC286126 — 0.00025 0 2.54 4.31
1556220_at — — — 7.62E11 1.07E05 2.51 4.5
240242_at — — — 0.00073 1.39E08 2.44 6.19
227480_at SUSD2 Sushi domain containing 2 — 0 4.44E05 2.19 5.17
Abbreviations: NON, nonanoic acid; SLS, sodium lauryl sulfate.
These genes were selected among the top 50 up- and downregulated transcripts at day 11. Genes occur in the list only if they were changed in the same
direction by both irritants. The top 50 genes were selected as those with the highest fold change among all significant (FDRo0.05) genes. Full top 50 lists are
shown in Supplementary Table S2 online.
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equal S100A7 upregulation visualized immunohistochemi-
cally at day 11 (Figure 3j-l). No changes in antibody staining
were observed during early time points.
Differential cyclooxygenase 2 (COX-2) protein expres-
sion between the two irritants was confirmed. The most
intense changes in immunostaining were observed in
stratum spinosum (Figure 3m-o) and stratum granulosum
(day 11, not shown). Induction of COX-2 protein could
be shown after 12 hour for NON, whereas SLS was only
able to induce this protein after cumulative exposure. Thus,
at least in the early irritation phase does COX-2 expression
seem to correlate with the transcription of its encoding
gene PTGS2.
Matrix metalloproteinase 3 (MMP3) was the most differ-
entially expressed transcript for combined early time points
(Supplementary Figure S2 online) and showed diffuse epi-
dermal staining that was not altered at any time points for any
of the irritants (not shown). Nuclear staining was, indeed,
significantly induced after 12 hour exclusively by SLS (P¼
0.02), and this change was sustained—although insignif-
icantly—for 4 and 24 hours (Figure 3p-r).
DISCUSSION
Serial sampling in a cumulative irritation study enabled us to
examine genome-wide transcriptional changes over time in
response to SLS and NON. Focus on the epidermal response
was given priority to minimize ‘‘noise’’ from the various
different cell types of the dermis, and analysis of the dermal
transcriptional response is thus excluded from this study. Two
essentially different situations were studied: (1) cumulative
irritation at a stage where clinical signs are observable,
epidermal homeostasis and barrier function are disturbed,
and healing processes are active; and (2) the early epidermal
response to a subclinical mild irritative insult where no
perturbation of barrier function could be shown (as deter-
mined by TEWL, Supplementary Table S1 online).
On the basis of sequential measurements, we observed a
difference in the number of transcripts induced by the two
irritants indicating that SLS may induce a transcriptional
response that is more enhanced, more protracted, and
possibly with an earlier onset compared with NON (Supple-
mentary Figure S2 online). Whether the observed differences
are caused by (1) irritant reaction kinetics, (2) irritant
concentrations, or (3) actual differences in the mechanisms
of action, cannot be answered unequivocally from this study
design. Therefore, these aspects must be kept in mind when
interpreting the results.
Interpretation of the initial epidermal response to mild irritant
exposure
Although a relatively small number of transcripts was initially
induced by NON compared with SLS, the response seems to
be a relevant one not far from responses induced by a variety
of other short-term exogenous stimuli such as UV light,
hyperosmotic stress, oxidative stress (Bender et al., 1997),
chemically induced carcinogenesis (Cheepala et al., 2009),
and jet fuel-induced skin irritancy in rats (McDougal et al.,
2007). Significantly upregulated pathways by NON include
inflammatory, proliferation/pro-survival pathways where
many of the contributing genes exhibit substantial overlap.
The overall picture is consistent with activation of MAPK
cascades (especially the extracellular signal-regulated kinase
(ERK) branch) that are well-known stress signal transduction
pathways crucial for keratinocyte proliferation, apoptosis,
and survival (Iversen et al., 2005). Selective activation of the
IL-6 pathway by NON, but not by SLS, is in line with previous
findings (Grangsjo et al., 1996).
Consistent with the involvement of MAPK signaling
is the robust upregulation of the DUSP1 and FOS transcripts.
DUSP1 negatively regulates MAPK by inactivation of
JUNK, ERK and p38, and thus, has an important role in the
termination of MAPK signaling (Abraham and Clark,
2006). FOS is a transcription factor that heterodimerizes
with members of the JUN family to form the transcription
factor complex. AP-1 is located downstream of MAPK
signaling, and its activation results in the transcription of a
wide array of genes important for epidermal homeostasis,
inflammation, and pathology (Zenz et al., 2008).
Although the immunomodulator DUSP1 was upregulated
for both irritants, other inhibitory effector arms in immune/
inflammatory response pathways (such as, peroxisome
proliferator-activated receptor a (PPAR-a), ubiquitin-depen-
dent proteolysis, and the upregulation of the anti-inflamma-
tory homeostatic protein annexin A1) were exclusively
associated with the NON response, thereby offering a
possible explanation to why NON induced the regulation
of relatively few transcripts compared with SLS within the first
24 hours after exposure. Of particular interest is the PPAR-a
pathway that was not only upregulated by NON but was
also among the most differentially involved pathways
when comparing NON and SLS. PPARs are ligand-activated
transcription factors of the nuclear hormone receptor super-
family that behave as negative regulators of the inflammatory
phase of skin repair/homeostasis (Icre et al., 2006). Topically
applied PPAR-a agonists have been shown to reduce 12-O-
tetradecanoylphorbol-13-acetate-induced skin irritation in
mice (Sheu et al., 2002). Noteworthy, PPAR ligands include
fatty acids (such as NON, speculatively) and eicosanoids that
might explain the solitary NON-induced activation of PPAR-
a signaling.
The transcription of both MMP3 and PTGS2 correlated
with their protein expression. To our knowledge, we are the
first to show in vivo induction of these innate immune-related
proteins just 30minutes after irritant exposure in human skin.
The non-extracellular (i.e., nuclear) location of MMP3 has
previously been shown in UVA photoprovoked skin (Jarvinen
et al., 2007), and this protein has important functions in
cellular proliferation, migration, apoptosis, and inflammation
through enzymatic cleavage of non-matrix substrates
(McCawley and Matrisian, 2001). Interestingly, one of its
substrates, IGFBP3, was less transcribed on exposure to SLS
compared with NON. Because MMP3-catalyzed cleavage of
IGFBP3 increases the bioavailability of IGF (Fowlkes, 1997),
the combined upregulation of MMP3 and downregulation of
IGFBP3 may act in concert to increase IGF bioactivity by SLS
but not by NON.
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Epidermal response to repeated skin irritation
The observed degree of cumulative ICD at the end of a 5þ 4
days exposure model was histologically very modest, and
microscopic examination is not an applicable tool for
distinguishing between SLS and NON cumulative reactions.
Thus, our results confirm what others have found previously:
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Figure 3. Histopathological changes at various time points for sodium lauryl sulfate (SLS) and nonanoic acid (NON). Acanthosis and sparse ortho-
hyperkeratosis is induced after cumulative exposure at day 11 (d11) for both irritants (a) shown for SLS at 0 hour (b) and d11 (c). The slight inflammatory
response, which is dominated by CD3þ T cells is hardly demonstrable until d11 (d) for both SLS and NON. Barely any CD3þ T cells at 0 hour (e), but a
perivascular increase at d11 (f). The change in MIB1 staining shows an identical pattern with an increase at d11 for both SLS and NON (g) and is shown for SLS at
0 hour (h) and d11 (i). The increase in nuclear staining of the basal and suprabasal cells indicates a proliferative response. S100A7 is upregulated for both NON
and SLS at d11 (j) in the upper epidermis, shown for NON at 0 hour (k) and d11 (l). There is a differential increase in cyclooxygenase 2 (COX-2) staining for NON
and SLS with a peak at 12 hour and at d11, respectively (m). The slight increase in staining of the keratinocytes in stratum spinosum
1
2 hour after NON exposure is
shown in o. There is no spinous staining at 0 hour, but a slight staining of the basal layer (n and o), equal for both irritants. The increase of matrix
metalloproteinase 3 (MMP3) staining of the stratum granulosum half an hour after SLS exposure is shown by many positive nuclei at 12 hour (p, r), but hardly any
at 0 hour (q). Significant changes from baseline (0 hour) and from the other irritant are designated by *and z, respectively. The magnification of all
microphotographs is identical; scale bar in c ¼ 0.1mm.
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diverse morphology in acute challenges cannot be corrobo-
rated in cumulative situations (Moon et al., 2001; Willis,
2006).
The 23 suggested biomarkers for cumulative ICD (Table 1)
were robustly regulated genes observed for both irritants at
day 11. Gene members of the epidermal differentiation
complex (Mischke et al., 1996) were upregulated. These
genes of the epidermal differentiation complex colocalize
within 2.05 kb on the 1q21 chromosome and are important
for terminal differentiation of human epidermis. Noteworthy,
other prominent epidermal differentiation complex gene
members, such as, loricrin, involucrin, and profilaggrin, were
not among the significantly regulated transcripts at any time
point in our experiment (not shown). The apoptosis-regulat-
ing protein survivin (encoded by BIRC5) and the putative
antimicrobial peptide lipocalin 2 were not previously
associated with ICD but have both been shown to have a
role in maintenance of skin homeostasis: Survivin is
upregulated in the epidermis in response to UVB (Dallaglio
et al., 2009), and lipocalin is upregulated in hyper-
proliferative skin diseases such as psoriasis and chronic
eczema (sic), but not acute allergic contact dermatitis
(Mallbris et al., 2002).
To our knowledge, loss of function of the tight junction
protein claudin 23, the cornified envelope precursor sciellin,
and the rate-limiting enzyme in sterol biosynthesis squalene
epoxidase (encoded by SQLE) is previously unreported in the
context of skin irritation. Although the expressions of other
claudins have been shown to be influenced by phorbol ester
exposure to murine skin (Arabzadeh et al., 2008), expres-
sion of claudin 23 in skin was never previously reported.
The expression of sciellin has not been described in any
pathological skin conditions; in contrast, sciellin null mice
have normal skin development and structure (Baden et al.,
2005). Downregulation of SQLE indicates altered epidermal
cholesterol biosynthesis. Although SQLE has not previously
been associated directly with skin disease, the oral admin-
istration of a squalene epoxidase inhibitor to dogs resulted in
dermatitis (Chugh et al., 2003). Thus, new genes of potential
diagnostic, therapeutic, and prognostic value have been
identified in the context of ICD and skin homeostasis.
In summary, we present new insights into the molecular
events in the epidermal response to two different
experimental irritants. Relevant genes/pathways were identi-
fied already 30minutes after exposure as was protein
expression. Early pathways involved in the initial phase of
skin irritancy were very different when comparing SLS
and NON, and differential expression for selected genes
could be confirmed at the protein level. The differences
reported may depend on experimental design and dose of
irritants applied. Twenty-three possible common biomarkers
for cumulative skin irritancy are accessible for further
validation.
In conclusion, although SLS and NON irritation had more
similar than dissimilar macro- and microscopic morphologi-
cal profiles in the initial and late exposure phase, gene
expression profiles are much different and worth exploring
further in future studies.
MATERIALS AND METHODS
Subjects
A total of 36 healthy human volunteers gave their written, informed
consent to participate. The study was performed in accordance with
the Declaration of Helsinki Principles and approved by the local
ethics committee (Videnskabsetisk komite´ for Region Syddanmark;
S-20070012). UV exposure, washing, and treatment of test sites were
not allowed during the study.
Irritant exposure
Eighteen volunteers (10 men, 8 women; mean age 28.7 years) were
exposed to 2% SLS (purity499.9%; Sigma Chemicals, St Louis, MO)
aqueous, and 18 volunteers (7 men, 11 women; mean age 25.9
years) were exposed to 10% NON (purity 99.3%; ABCR, Karlsruhe,
Germany) in n-propanol. Skin irritation was accomplished in a
cumulative open application test as previously described (Andersen
et al., 2006). Briefly, the volar forearms were exposed 10minutes for
5þ 4 days using a 20mm diameter open chamber.
In addition, three sites were noncumulatively irritated
(10minutes single exposure) and named 12, 4, or 24 hours according
to the elapsed time from end of exposure till biopsies were taken.
Evaluation of skin irritancy
Clinical assessment. Visual scoring was performed in accordance
with the European Society of Contact Dermatitis guideline on
cumulative/subacute SLS irritation (Tupker et al., 1997). The target
level of irritation at day 11 was a score of at least 2 but preferably not
higher than 4 corresponding to a moderate reaction.
Biometric assessment. Skin barrier integrity was assessed by
measuring the TEWL using a DermaLab (Cortex, Hadsund, Denmark)
TEWL probe. Skin color reflectance was determined using a
colorimeter (Minolta CR300, Osaka, Japan) quantifying erythema.
Stratum corneum hydration was estimated by measuring
conductance with the DermaLab (Cortex) moisture pin probe.
Means from triplicate measurements were used for colorimetry and
hydration.
Skin biopsies and separation of epidermal sheets
Double biopsies (one 3mm and one 4mm punch biopsy with a
distance of approximately 3mm) were taken from preselected sites
according to an incomplete block design with each subject
contributing with biopsies from three of the five possible sites, i.e.,
0 hour (control), 12 hour, 4 hours, 24 hours, and day11. Control
biopsies from 0hour sites (n¼ 36) were secured from all participants.
Biopsies (3mm) were formalin fixed and paraffin embedded.
Ammonium thiocyanate-induced dermo-epidermal separation of
4mm biopsies was performed as previously described (Clemmensen
et al., 2009). The epidermal sheets were stored in RNAlater (Applied
Biosystems/Ambion, Austin, TX) at 41C for 48 hours and then at
201C until further processing.
RNA extraction and hybridization to microarrays
Epidermal specimens were homogenized in a TissueLyser (Qiagen,
Valencia, CA) and RNA extracted using the RNeasy Micro Kit
(Qiagen) following the manufacturer’s instructions. RNA integrity
was assessed on a Bioanalyzer (Agilent, Santa Clara, CA). RNA
(500 ng) was amplified with the MessageAmp II Biotin Enhanced
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kit (Applied Biosystems/Ambion) and hybridized to Affymetrix
GeneChip HG U133 plus 2.0.
Selection of samples for the microarray experiment
RNA from 48 samples was hybridized to microarrays. Uninterrupted
series of three samples per subject were preferred. The number of
chips was expanded for the time point 12 hour, which was of special
interest with respect to identifying initial differences between the two
irritants. The samples from time points 0 hour (n¼ 9), 12 hour (n¼ 6),
4 hours (n¼ 3), 24 hours (n¼ 3), and day 11 (n¼ 3) originated from 9
of the 18 SLS-irritated subjects and from 9 of the 18 NON-irritated
subjects. The 18 subjects who contributed with samples hybridized
to microarrays had a mean visual sum score at day 11 of 3.58 (range
1.5–10).
Histopathology
Sections (3 mm) were cut from the paraffin blocks and stained with
hematoxylin and eosin and immunohistochemically with antibodies
to COX-2 (NeoMarkers, Fremont, CA), S100A7 (Abcam, Cambridge,
UK), MMP3 (Abcam), CD3 (Dako, Glostrup, Denmark), and MIB1
(Immunotech, Glendale, CA). Visual grading through four steps (0–3)
was applied for hyperkeratosis, acanthosis, and perivascular
inflammation. CD3-positive cells were counted in a subepidermal
area of 1mm2. Epidermal cytoplasmic staining was graded by the
visual four-step scale for S100A7 and COX-2, whereas nuclear
staining was evaluated by counting positive nuclei along 1mm of
full-thickness epidermis (MIB1 and MMP3). The cytoplasmic staining
of MMP3 was performed automatically on the ACIS III (Dako). The
epidermal cytoplasmic staining with anti-COX-2 segregated into a
diffuse, dense staining of the basal layer, a less intense sporadic
staining of the spinous layer, and a totally different, distinct,
paranuclear, granular staining of the granular layer. Consequently
each of these three epidermal compartments was evaluated
separately. All evaluations were blinded.
Data analysis
Microarray experiment. Raw data have been deposited at NCBI’s
Gene Expression Omnibus and are accessible through GEO Series
accession number GSE18206. CEL files were normalized using
the quantile method in R environment (http://cran.r-project.org/)
using all genes in data sets. The design of our experiment was
characterized by (1) a treatment effect between two groups of
subjects receiving different irritants, (2) an effect of time, and (3)
subjects contributed with samples from different time points creating
an unbalanced data structure. During the experiment, the gene
expression level for an individual was measured repeatedly over
time such that the data for an individual were correlated although at
different time points. Considering the specific experiment design and
data structure, we applied the LME model to our data with fixed
effects for the treatment and for the time effect together with possible
interactions between them and random effect for individual
differences; i.e., we model
~y¼X~bþU~xþ~e
Here,~y stands for the vector of measured gene expression levels,
X and U are the known design matrices,~b is the fixed effect vector to
be estimated,~x is the vector for the random effects, and~e is the vector
of residuals. Nested models with only the fixed effect for one
treatment were also fitted for specific time points.
LME and t-test calculations were performed in R using FDR to
adjust for multiple testing. Hierarchical clustering was performed
using TM4 Multi Experiment Viewer and Euclidian distance.
Pathway analysis was performed using a collection of 639 canonical
pathways in Gene Set Enrichment Analysis (http://www.broad.
mit.edu/gsea) correcting for multiple testing with the family-wise
error rate. Unpaired pathway analysis was performed separately for
each irritant with 6 vs. 12 chips (12 hour) or 3 vs. 15 chips (4 hours,
24 hours, and day 11) omitting 0 hour samples for the examined time
point. Hypergeometric test for canonical pathway overlap was
conducted with MSigDB.
Histopathology. For identification of significantly changed expres-
sion from 0hour samples, we used the Wilcoxon signed rank test.
For direct comparison between SLS and NON groups, we used the
Wilcoxon rank sum test. a Values o 0.05 were considered
significant.
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